EarFlo: A Non-Invasive Treatment for Otitis Media With Effusion & Eustachian Tube Dysfunction in Adults
Part of paid clinical trials in Pittsburgh, Pennsylvania.
- Sponsor
- Philip Perez
- Study ID
- NCT07777302
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Eustachian Tube Dysfunction
- Otitis Media With Effusion
- Otitis Media With Effusion (OME)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- EarFlo Device — DEVICEThe EarFlo device is a non-invasive, cup-based device used during swallowing to help equalize middle ear pressure. By delivering a controlled puff of air through the nose during swallowing, it assists Eustachian tube opening to relieve negative middle ear pressure. Participants will use the device once during a single clinic visit while drinking water or a beverage of their choice. No surgery or invasive procedures are involved.
Study Details
This study evaluates the use of the EarFlo device in adults with clinically confirmed Eustachian tube dysfunction and/or otitis media with effusion. The purpose of the study is to assess the safety, tolerability, and short-term effects of device use on ear pressure symptoms and middle ear function. Participants will complete a brief symptom questionnaire, undergo routine ear examinations and testing, and use the EarFlo device once during a clinic visit. Ear examination and testing will be repeated after device use to evaluate any short-term changes. This study involves a single study visit and does not include any surgical or invasive procedures.
Key Dates
- First listed
- Aug 20, 2026
- Start date
- Aug 27, 2026
- Status verified
- Aug 2026
- Primary completion
- Nov 30, 2027
- Completion
- May 15, 2028
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: EarFlo Intervention ArmParticipants in this single arm will undergo baseline assessments, use the EarFlo device once during a clinic visit, and complete post-use assessments to evaluate short-term changes in ear symptoms and middle ear function.
Primary Outcome Measure
Change in middle ear pressure and compliance measured by tympanometry following single use of the EarFlo device [ Time Frame: Immediately before EarFlo device use (baseline) and immediately after EarFlo device use (post-intervention) during the single study visit ]
Central Contacts
- Zarna P Lalwani, BDS, MPH
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Eye and Ear Institute / UPMC Presbyterian | Pittsburgh | Pennsylvania | 15213 | - |
| UPMC Mercy | Pittsburgh | Pennsylvania | 15219 | - |
| UPMC Montefiore | Pittsburgh | Pennsylvania | 15213 | - |
| UPMC Shadyside | Pittsburgh | Pennsylvania | 15232 | - |
Find similar trials in Pittsburgh, PA
Related Studies
- Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)PHASE2 · Recruiting · Cedars-Sinai Medical Center · Los Angeles, California
- Coherent Optical Detection of Middle Ear DiseaseRecruiting · Medical College of Wisconsin · Wauwatosa, Wisconsin
- Evaluation of Outcomes Following In-office Tympanostomy Using the Tula® System: a Prospective, Multi-center RegistryRecruiting · Smith & Nephew, Inc. · Louisville, Kentucky
- Active vs. Passive VR During Office-based ENT ProceduresNot Yet Recruiting · Cedars-Sinai Medical Center · Los Angeles, California